Alphabiome raised $8M in Seed funding led by AIX Ventures to expand operations and enhance R&D efforts.
Amount Raised
$8 Million
Round Type
Seed
Tel AvivBiotechnologyArtificial IntelligenceGeneticsMachine LearningInvestors
Description
Alphabiome, a Tel Aviv-based company, raised $8M in Seed funding to advance technology that extracts genetic biomarkers from microbial DNA. The funding round was led by AIX Ventures and aims to expand operations and R&D. Alphabiome uses a proprietary AI model to decode the human microbiome. They recently conducted a trial identifying over 10,000 complex microbe-derived biomarkers related to drug efficacy.
Who to call at Alphabiome, and when
A new round usually means Alphabiome is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Alphabiome raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Alphabiome, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Alphabiome. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Alphabiome raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Alphabiome raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.